Skip to main content
OpenTrials
Completed

NCT Number: NCT01390194

Rapid 10-Minute Liver MRI Protocol in Patients With Suspected Hepatocellular Carcinoma

The purpose of this study to assess the image quality of the rapid magnetic resonance imaging (MRI) compared to the standard MRI.

Completed

Looking for future studies?

Notify Me

Key information

About this study

This is a pilot study to compare a rapid 10-minute liver magnetic resonance imaging (MRI) protocol to standard MRI in participants with suspected hepatocellular carcinoma.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • underlying liver disease
  • have a lesion on a prior imaging study
  • must have prior standard MR

Exclusion criteria

  • Contra-indication for MR imaging including pacemaker, claustrophobia, pregnancy, electronic or vascular devices that are contraindicated;
  • patients with severe kidney dysfunction

Treatment and study plan

Primary outcomes

  1. image quality outcome

    Time frame: 2 years

    Two MRI exams will be evaluated by two radiologists based on a number of items.

Sponsors and collaborators

Lead sponsor

University of Nebraska

Other

Collaborators

  • Bracco Diagnostics, Inc
  • Philips Medical Systems

Registry information

Official study title

Rapid 10-Minute Liver MRI Protocol in Patients With Suspected Hepatocellular Carcinoma: A Pilot Study to Assess the Image Quality (Multitransmit Body MRI Program)

Important dates

Study start
2011
Primary completion
2015
Study completion
2015
First posted
Jul 8, 2011
Registry last updated
Sep 6, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.